British pound climbs as government makes U-turn on tax cut plan    Egypt's net foreign assets decline again to reach $925 million in August    Turkey's inflation jumps to 83% highest level in nearly in 24 years    Egypt's FM heads to Congo Today to attend PRECOP27 conference    King Charles III won't attend COP27 in Egypt, following PM Truss advice    Swedish coastguard says: Fourth leak discovered on Nord Stream pipelines    Egyptian gecko invades Israel    Egypt welcomes back Russian flights on 1st October    Egypt launches 200 Years of Continuing Science tourism campaign    Egypt, UAE partner on sustainable waste management in Sharm el-Sheikh ahead of COP27    QNB Group names TikToker Khaby Lame official FIFA World Cup Qatar 2022 brand ambassador    Three possible scenarios as Egypt's central bank governor resigns – MP    Adele is living a love story, wants to be a homemaker    In Photos: Egypt swears in 13 new ministers after major Cabinet reshuffle    Egypt's Sisi names 13 ministers in Cabinet reshuffle    Spain: prosecutor seeks 8 years sentence for Shakira over tax evasion    Egypt: Alamein Art Festival kicks off a collection of recycled installations    Egypt's athlete Basma Emad wins bronze in weightlifting in Mediterranean Games    Maha karara joins AAIB as Head of Corporate Communications, Sustainability    Egypt works on charting cooperation strategies with international institutions for 5 years: Al-Mashat    Over 2.4 million newborns examined for hearing impairment: Health Ministry    Netflix releases trailer of Arab adaption of 'Perfect Strangers' film    Balqees to headline concert celebrating launch of streaming giant LIVENow in MENA    Sawsan Badr to be honoured at Aswan Women Film Festival    MP Abdel Hady Al-Qasby calls government to facilitate and support NGOs    Al-Sisi follows up on 'Great Transfiguration Project' in St. Catherine    Cairo, London stress need to strengthen cooperation to face climate change    Foreigners account for 22.6% of Egypt's T-bills issuances in 1H 2021: CBE    Egypt's ambassador to Italy passes away    Egypt confirms readiness to help African countries face terrorism and extremism    An estimated 235 million people needed humanitarian assistance and protection in 2021, an increase of 40% compared to 2020: IOM Egypt    Egypt, DRC discuss water cooperation during WYF    Egypt, DR Congo discuss boosting bilateral cooperation during WYF    Cameroonian police probe assault on three Algerian journalists covering AFCON    Pharaohs start AFCON 2021 campaign with fierce clash against Nigeria    Foreign Ministry opens capacity building course for French-speaking African diplomats    Russia says it's in sync with US, China, Pakistan on Taliban    It's a bit frustrating to draw at home: Real Madrid keeper after Villarreal game    Shoukry reviews with Guterres Egypt's efforts to achieve SDGs, promote human rights    Sudan says countries must cooperate on vaccines    Johnson & Johnson: Second shot boosts antibodies and protection against COVID-19    Egypt to tax bloggers, YouTubers    Egypt's FM asserts importance of stability in Libya, holding elections as scheduled    We mustn't lose touch: Muller after Bayern win in Bundesliga    Egypt records 36 new deaths from Covid-19, highest since mid June    Egypt sells $3 bln US-dollar dominated eurobonds    Gamal Hanafy's ceramic exhibition at Gezira Arts Centre is a must go    Italian Institute Director Davide Scalmani presents activities of the Cairo Institute for ITALIANA.IT platform    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



Halt of coronavirus trial is "safety valve" at work: Fauci
Published in Ahram Online on 09 - 09 - 2020

The top US infectious disease expert said AstraZeneca's suspension of final testing of its COVID-19 vaccine candidate shows ``one of the safety valves'' built into the studies to spot any potential problems.
``It's unfortunate that it happened and hopefully they'll be able to proceed along with the remainder of the trial. But you don't know _ they need to investigate it further,'' Dr. Anthony Fauci, infectious diseases chief at the National Institutes of Health, told ``CBS This Morning'' on Wednesday.
Late Tuesday, AstraZeneca announced its final-stage studies are on temporary hold while the company investigates whether a research volunteer's ``potentially unexplained illness'' is a side effect of the shot or a coincidence.
Behind-the-scenes monitors known as the ``data and safety monitoring board'' in Britain paused vaccinations while alerting its safety counterparts in the US, said Dr. Moncef Slaoui of Operation Warp Speed, the Trump administration's vaccine development program.
Late last month, AstraZeneca began recruiting 30,000 people in the US for its largest study of the vaccine. It also is testing the vaccine, developed by Oxford University, in thousands of people in Britain, and in smaller studies in Brazil and South Africa.
Scientists around the world have been scrambling to develop a vaccine against the coronavirus since the pandemic began. Nearly 900,000 deaths have been reported in the pandemic.
An AstraZeneca spokesperson confirmed the pause in vaccinations covers studies in the US and other countries. The company would not provide further details of the illness.
Earlier stage studies of the vaccine hadn't revealed any serious side effects.
``It's important to point out that that's the reason why you have various phases of trials, to determine if in fact these candidates are safe,'' Fauci said. ``It's really one of the safety valves you have on clinical trials such as this.''
Nor is it uncommon for pauses in research to investigate if a reaction is really related to the vaccine or not, he said.
``I'm not concerned. I simply think is how research works and what we want research to be doing,'' said Dr. Carlos del Rio of Emory University, who isn't involved with the AstraZeneca testing, told reporters Wednesday.
Two other vaccines are in huge, final-stage tests in the United States, one made by Moderna Inc. and the other by Pfizer and Germany's BioNTech. Those two vaccines work differently than AstraZeneca's, and the studies already have recruited about two-thirds of the needed volunteers.
The development came the same day that AstraZeneca and eight other drugmakers issued an unusual pledge, vowing to uphold the highest ethical and scientific standards in developing their vaccines.
The announcement follows worries that President Donald Trump will pressure the US Food and Drug Administration to approve a vaccine before it's proven to be safe and effective.
The U.S. has invested billions of dollars in efforts to quickly develop multiple vaccines against COVID-19. But public fears that a vaccine is unsafe or ineffective could be disastrous, derailing the effort to vaccinate millions of Americans.


Clic here to read the story from its source.